Orphan drug designation
ABM-1310 receives Orphan Drug Designation from the FDA for Glioblastoma
SG Tylor
Source – ABM Therapeutics ABM Therapeutics has received orphan drug designation from the FDA for ABM-1310, a novel small molecule ...
FDA Issues ODD for Gallium Maltolate for Pediatric GBM
SG Tylor
Imaging Biometrics announced that gallium maltolate (GaM) has received orphan drug designation (ODD) from the FDA for the treatment of ...
